Medifast director buys $1.1M of MED stock
Medifast
- $1,133,816.27[1]
- 94,036[1]
Medifast (MED) director Parsa Kiai bought $1,133,816.27 of company stock on Nov 18, 2026, a Form 4 filed with the SEC on Nov 20, 2026 shows. The filing reports a purchase (code P), submitted 2 days after the trade.[1]
| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Parsa Kiai | 2026-11-18 | P | Purchase | 8,630 | $12.16 | 721,521 | 2 days |
| Common Stock | Parsa Kiai | 2026-11-18 | P | Purchase | 256 | $12.16 | 21,345 | 2 days |
| Common Stock | Parsa Kiai | 2026-11-19 | P | Purchase | 82,700 | $12.05 | 804,221 | 2 days |
| Common Stock | Parsa Kiai | 2026-11-19 | P | Purchase | 2,450 | $12.05 | 23,795 | 2 days |
What does the Form 4 show?
It lists 4 transactions for 94,036 shares, at an average $12.06 a share. Parsa Kiai owned 23,795 shares after the last one.[1]
What else has the filing history shown?
MED insider trading activity
In open-market trades dated in the last 90 days, 1 insider bought $1.8M and 1 insider sold $226K, all of it under preset trading plans, per Form 4 filings.
- Parsa Kiai (Director) bought 147,733 shares for $1.8M, last filed Nov 20.
- Daniel R. Chard (Director) sold 19,089 shares for $226K under a preset plan, last filed Oct 1.
Get MED alerts
Set a MED price alert, or get one when a fund, insider or politician you follow trades.
Sources
Keep reading
Built by fixed rules from the filing as filed, with no AI writing. A filing does not show why anyone traded. Report a correction.